查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1657673

全球笔针市场按类型、长度、应用、购买模式、医疗保健环境和地区划分 - 预测至 2030 年

Pen Needles Market by Type, Length, Setting, Application, Mode of Purchase - Global Forecast to 2030
出版日期: | 出版商: MarketsandMarkets | 英文 286 Pages | 商品交期: 最快1-2个工作天内

价格

预计笔式针头市场规模将从 2024 年的 18.1 亿美元成长到 2030 年的 30.8 亿美元，预测期内的复合年增长率为 9.2%。

随着老龄化，人们更容易出现胰岛素抗性、胰臟功能下降、高血压和肥胖等併发症，增加糖尿病的风险。随着老龄化，身体产生胰岛素来调节血糖值的能力会下降，从而增加罹患第 2 型糖尿病的可能性。此外，老年人体力活动减少和生活方式的改变也是导致糖尿病发病率上升的原因之一。随着老龄化的增长，糖尿病的盛行率不断上升，这对胰岛素注射装置（尤其是笔式针头）的需求增加有着简单而直接的影响。胰岛素注射是老年人糖尿病管理的重要组成部分，尤其是患有第 1 型或晚期第 2 型糖尿病的患者。与传统注射器相比，笔式针头使用起来简单、方便且疼痛减轻，特别适合老年人。许多老年人所患的其他疾病包括关节炎，这主要会妨碍使用注射器，导致人们普遍偏好使用笔针的胰岛素笔。

研究范围
调查年份 2022-2030
基准年 2023
预测期 2024-2030
考虑单位 金额（美元）
按细分市场 按类型、长度、用途、购买方式、医疗环境、地区
目标区域 北美、欧洲、亚太地区、中东和非洲、拉丁美洲、海湾合作委员会国家

标准针头在全球市场上市场占有率主导地位，因为其与用于胰岛素注射和其他注射药物的大多数笔式註射器具有广泛的兼容性。这些针头经过开发，可以适用于多种胰岛素笔，适合所有类型的患者。它的简单性和可负担性使其广受欢迎，在人口对成本较为敏感的地区你会发现它的易用性。标准笔针也适合第 1 型和第 2 型糖尿病患者。因此，标准笔针被广泛用于所有这些情况，并且患者及其医疗保健提供者将其作为首选。

由于电子商务平台提供的优势和便利，全球笔式针头市场的线上采购部分预计将在预测期内呈现最高的成长率。例如，该网站提供有竞争力的价格，有时还提供折扣、促销优惠和捆绑交易，可以让客户以更便宜的价格购买笔式针头。除此之外，网路购物的吸引力比传统零售店更大，因为更容易比较产品、阅读客户评论并获得全面的产品和尺寸。线上平台的推出也将增加偏远地区或行动不便的客户的便利性，因为他们可以在家中收到书写工具。采用电子商务更方便、更具成本效益，因此网上购物产业必将强劲成长。

本报告研究了全球笔针市场，并根据类型、长度、应用、购买模式、医疗环境、区域趋势和公司概况对市场进行了详细的分析。

目录

第 1 章 简介

第二章调查方法

第三章执行摘要

第 4 章重要考察

第五章 市场概况

  • 介绍
  • 市场动态
  • 产业趋势
  • 赎回情况
  • 定价分析
  • 价值链分析
  • 生态系分析
  • 波特五力分析
  • 供应链分析
  • 监管分析
  • 贸易分析
  • 专利分析
  • 主要相关人员和采购标准
  • 案例研究分析
  • 技术分析
  • 2025-2026 年重要会议与活动
  • 邻近市场分析
  • 人工智慧/生成式人工智慧对注射笔针头市场的影响
  • 影响客户业务的趋势/干扰
  • 未满足需求分析
  • 投资金筹措场景

第 6 章 笔针市场，依类型

  • 介绍
  • 标准笔针
  • 安全笔针

7. 笔针市场，依长度划分

  • 介绍
  • 8mm
  • 5mm
  • 6mm
  • 4mm
  • 12mm
  • 10mm

第 8 章 笔针市场，依应用

  • 介绍
  • 胰岛素治疗
  • Glucagon-Like Peptide-1疗法
  • 生长激素荷尔蒙疗法
  • 骨质疏鬆症
  • 其他的

第九章。

  • 介绍
  • 处方笺购买
  • 场外购买
  • 线上购买
  • 其他的

第 10 章。

  • 介绍
  • 居家医疗
  • 医院和诊所
  • 其他的

第 11 章 笔针市场（按地区）

  • 介绍
  • 北美洲
    • 北美宏观经济展望
    • 美国
    • 加拿大
  • 欧洲
    • 欧洲宏观经济展望
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 其他的
  • 亚太地区
    • 亚太宏观经济展望
    • 日本
    • 中国
    • 澳洲和纽西兰
    • 印度
    • 韩国
    • 东南亚
    • 其他的
  • 拉丁美洲
    • 拉丁美洲宏观经济展望
    • 巴西
    • 墨西哥
    • 阿根廷
    • 其他的
  • 中东和非洲
    • 慢性病增加将推动成长
    • 中东和非洲宏观经济展望
  • 海湾合作委员会国家
    • 可支配所得增加推动经济成长
    • 海湾合作委员会国家的宏观经济展望

第十二章 竞争格局

  • 介绍
  • 主要参与企业的策略/优势
  • 2019 至 2023 年收益分析
  • 2023 年市场占有率分析
  • 公司估值矩阵：主要参与企业，2023 年
  • 公司估值矩阵：Start-Ups/中小企业，2023 年
  • 估值及财务指标
  • 竞争场景
  • 品牌/产品比较
  • 主要企业研发支出

第十三章 公司简介

  • 主要参与企业
    • EMBECTA CORP.
    • NOVO NORDISK A/S
    • B. BRAUN SE
    • YPSOMED
    • TERUMO CORPORATION
    • NIPRO
    • OWEN MUMFORD
    • ARKRAY, INC.
    • ULTIMED, INC.
    • HINDUSTAN SYRINGES & MEDICAL DEVICES LTD.
    • MONTMED
    • HTL-STREFA
    • ALLISON MEDICAL, INC.
    • GLUCORX LIMITED
    • BERPU MEDICAL TECHNOLOGY CO., LTD.
  • 其他公司
    • VAN HEEK MEDICAL
    • SIMPLE DIAGNOSTICS
    • IYON HEALTH MEDICAL
    • LINKS MEDICAL PRODUCTS INC.
    • MHC MEDICAL PRODUCTS, LLC
    • ADVACARE PHARMA
    • ARTSANA SPA
    • PROMISEMED MEDICAL DEVICES, INC.
    • TRIVIDIA HEALTH, INC.
    • VOGT MEDICAL VERTRIEB GMBH

第十四章 附录

Product Code: MD 2851

The pen needles market is projected to reach USD 3.08 Billion by 2030 from USD 1.81 Billion in 2024 at a CAGR of 9.2% during the forecast period. The elderly are susceptible, due to their age, to insulin resistance, a decrease in pancreatic function, and other comorbid conditions, including hypertension and obesity, which raise the risk of developing diabetes. As people age, the body becomes less responsive to insulin's role in regulating blood sugar, hence increasing the chances of developing Type 2 diabetes. In addition, the reduction in physical activity among older adults, coupled with lifestyle changes, contributes to rising trends of the condition. The increasing incidence rate of diabetes with age has simple direct implications concerning the increased desire for insulin administration devices, especially the pen needles. Insulin injections are an essential component of diabetes management among elderly patients, especially patients with Type 1 or advanced Type 2 diabetes. Ease of use, convenience, and reduced pain compared to traditional syringes make the pen needle particularly suitable for older adults. Other conditions most of the elderly suffer from include arthritis, which could primarily hinder them using syringes, hence developing the preference for insulin pens that use pen needles.

Scope of the Report
Years Considered for the Study2022-2030
Base Year2023
Forecast Period2024-2030
Units ConsideredValue (USD)
SegmentsBy Type, Length, Application, Mode of Purchase, Setting and Region
Regions coveredNorth America, Europe, Asia Pacific, Middle East & Africa, Latin America, and the GCC Countries

"The standard pen needles segment is accounted for the largest share of global pen needles market."

The market share of pen needles in the global market is dominated by the standard ones because of their wide compatibility with most of the pen injectors used for insulin administration and other injectable drugs. These needles are developed to be able to fit in a variety of insulin pens, making them available to patients across all demographics.Their simplicity and affordability make them popular, and their ease of use is something that is found in regions whose populations are rather cost-sensitive. Standard pen needles are also apt for Type 1 and Type 2 diabetes patients. Other patients also require injectable medications for some other conditions; hence, standard pen needles find wide usage in all these conditions, making the patients and their healthcare providers retain them as a first choice for their use.

"Online purchase segment will grow at the highest CAGR during the forecast period of the global pen needles market."

The online purchase segment of the global pen needles market is expected to have the highest growth rate during the forecast period due to the benefits and convenience that e-commerce platforms have provided. For instance, the websites provide competitive prices and, sometimes, offer discounts, promotional offers, and bundle deals that can make the purchase of pen needles cheaper for customers. Apart from this, the appeal of online shopping is greater than traditional retail shops due to more ease in product comparison, reading customer reviews, and availability of a comprehensive range of products and sizes. The availability on online platforms also increases the accessibility for customers located at remote locations or those with some mobility issues since they can receive their pen needles at home. E-commerce adoption, with more convenience and cost-effectiveness, ensures that the segment of online purchases is going to grow strongly.

"North America to witness the substantial growth rate during the forecast period."

The pen needles market is segmented into North America, Europe, Asia Pacific, Latin America, the Middle East & Africa and GCC Countries based on the region type. In 2024, the Asia Pacific region is projected to exhibit the highest CAGR during the forecast period. However, North America accounts for the largest market share of the pen needles market in 2024. This is largely because of the health care systems that are advanced to facilitate better access to diabetes care. The U.S. and Canada have a well-developed medical infrastructure, making it easy for patients to reach pen needles for insulin delivery devices. Furthermore, with millions of people suffering from diabetes in these regions, there is high demand for effective, as well as user-friendly, delivery solutions. Pen needles are popular for their convenience, ease of use, and minimal discomfort. It is the preferred way to manage Type 1 and Type 2 diabetes. With extensive healthcare coverage, a high patient awareness level, and a large diabetic population, North America is the most significant market for pen needles.

A breakdown of the primary participants (supply-side) for the pen needles market referred to for this report is provided below:

  • By Company Type: Tier 1-22%, Tier 2-36%, and Tier 3-42%
  • By Designation: C-level-23%, Director Level-28%, and Others-49%
  • By Region: North America-38%, Europe-29%, Asia Pacific-23%, Latin America- 6%, and Middle East and Africa- 1% and GCC Countries- 3%

Prominent players in this market include Embecta Corp. (US), Novo Nordisk A/S (Denmark), Ypsomed AG (Switzerland), B. Braun SE (Germany), Owen Mumford (UK), Terumo Corporation (Japan), NIPRO Corporation (Japan), Allison Medical, Inc. (US), AdvaCare Pharma (US), Berpu Medical Technology Co., Ltd. (China), ARKRAY, Inc. (Japan), GlucoRx Limited (UK), HTL-STREFA (Poland), UltiMed, Inc. (US), Hindustan Syringes and Medical Devices (India), Artsana Group (Italy), PromiseMed Medical Devices Inc. (Canada), Montmed, Inc. (Canada), Trividia Health, Inc. (US), VOGT Medical Vertrieb GmbH (Germany), Van Heek Medical (Netherlands), Simple Diagnostics (US), IYON Medical (Turkey), Links Medical Products, Inc. (US), and MHC Medical Products, LLC (US).

Research Coverage:

The market study covers the pen needles market across various segments. It aims at estimating the market size and the growth potential of this market across different segments by type, length, application, mode of purchase, setting and region. The study also includes an in-depth competitive analysis of the key players in the market, along with their company profiles, key observations related to their product and business offerings, recent developments, and key market strategies.

Reasons to Buy the Report

This report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them garner a greater share of the market. Firms purchasing the report could use one or a combination of the below-mentioned strategies to strengthen their positions in the market.

This report provides insights on:

  • Analysis of Market Dynamics: Drivers (rising incidence of chronic diseases, favorable reimbursements in certain countries, and decreasing prices of insulin formulations) restraints (rising pet care costs, poor reimbursement scenario in emerging countries, and needle anxiety) opportunities (growing preference for biosimilar drugs, emerging economies to offer high-growth potential, and rising healthcare expenditure on diabetes), and challenges (implementation of regulations for safety pen needles, reuse of pen needles, and misuse of injection pens)
  • Services/Innovations: Detailed insights on upcoming technologies, research & development activities, and new product launches in the pen needles market.
  • Market Development: Comprehensive information on the lucrative emerging markets, components, demographics, end-user, and region.
  • Market Diversification: Exhaustive information about the product portfolios, growing geographies, recent developments, and investments in the pen needles market.
  • Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, and capabilities of the leading players in the pen needles market like Embecta Corp. (US), Novo Nordisk A/S (Denmark), Ypsomed AG (Switzerland), B. Braun SE (Germany), and Terumo Corporation (Japan).

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
    • 1.2.1 INCLUSIONS & EXCLUSIONS
    • 1.2.2 MARKET SEGMENTATION
    • 1.2.3 YEARS CONSIDERED
    • 1.2.4 CURRENCY CONSIDERED
  • 1.3 LIMITATIONS
  • 1.4 STAKEHOLDERS
  • 1.5 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • 2.1.1 SECONDARY DATA
      • 2.1.1.1 Key data from secondary sources
    • 2.1.2 PRIMARY DATA
      • 2.1.2.1 Key data from primary sources
      • 2.1.2.2 Key industry insights
  • 2.2 MARKET SIZE ESTIMATION
  • 2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
  • 2.4 MARKET SHARE ANALYSIS
  • 2.5 METHODOLOGY-RELATED LIMITATIONS
  • 2.6 STUDY ASSUMPTIONS
  • 2.7 RISK ASSESSMENT

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

  • 4.1 PEN NEEDLES MARKET OVERVIEW
  • 4.2 ASIA PACIFIC: PEN NEEDLES MARKET, BY LENGTH AND COUNTRY (2024)
  • 4.3 GEOGRAPHIC GROWTH OPPORTUNITIES
  • 4.4 REGIONAL MIX

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • 5.2.1 DRIVERS
      • 5.2.1.1 Rising incidence of chronic diseases
      • 5.2.1.2 Favorable reimbursements in certain countries
      • 5.2.1.3 Growing adoption of self-administration
      • 5.2.1.4 Decreasing prices of insulin formulations
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 Alternative methods of drug delivery
      • 5.2.2.2 Poor reimbursement scenario in emerging markets
      • 5.2.2.3 Needle anxiety
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Growing preference for biosimilar drugs
      • 5.2.3.2 Emerging economies to offer high-growth potential
      • 5.2.3.3 Rising healthcare expenditure on diabetes
      • 5.2.3.4 Implementation of regulations for safety pen needles
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Reuse of pen needles
      • 5.2.4.2 Misuse of injection pens
  • 5.3 INDUSTRY TRENDS
    • 5.3.1 GROWING PREFERENCE FOR SAFETY-ENGINEERED PEN NEEDLES
    • 5.3.2 RISING ADOPTION OF SHORTER AND ULTRA-THIN NEEDLES
  • 5.4 REIMBURSEMENT SCENARIO
  • 5.5 PRICING ANALYSIS
    • 5.5.1 INDICATIVE SELLING PRICE OF PEN NEEDLES, BY KEY PLAYER, 2024
    • 5.5.2 AVERAGE SELLING PRICE TREND OF STANDARD PEN NEEDLES, BY REGION, 2022-2024
  • 5.6 VALUE CHAIN ANALYSIS
  • 5.7 ECOSYSTEM ANALYSIS
  • 5.8 PORTER'S FIVE FORCES ANALYSIS
    • 5.8.1 INTENSITY OF COMPETITIVE RIVALRY
    • 5.8.2 BARGAINING POWER OF SUPPLIERS
    • 5.8.3 BARGAINING POWER OF BUYERS
    • 5.8.4 THREAT OF SUBSTITUTES
    • 5.8.5 THREAT OF NEW ENTRANTS
  • 5.9 SUPPLY CHAIN ANALYSIS
  • 5.10 REGULATORY ANALYSIS
    • 5.10.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • 5.10.2 REGULATORY FRAMEWORK
      • 5.10.2.1 North America
        • 5.10.2.1.1 US
        • 5.10.2.1.2 Canada
      • 5.10.2.2 Europe
      • 5.10.2.3 Asia Pacific
        • 5.10.2.3.1 Japan
        • 5.10.2.3.2 China
        • 5.10.2.3.3 India
  • 5.11 TRADE ANALYSIS
    • 5.11.1 TRADE ANALYSIS OF NEEDLES, CATHETERS, AND CANNULAE USED IN MEDICAL, SURGICAL, DENTAL, OR VETERINARY SCIENCES (HS CODE 901839)
    • 5.11.2 EXPORT DATA (HS CODE 901839), 2019-2023
    • 5.11.3 IMPORT DATA (HS CODE 901839), 2019-2023
  • 5.12 PATENT ANALYSIS
    • 5.12.1 PATENT PUBLICATION TRENDS FOR PEN NEEDLES
    • 5.12.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS
  • 5.13 KEY STAKEHOLDERS & BUYING CRITERIA
    • 5.13.1 KEY STAKEHOLDERS IN BUYING PROCESS
    • 5.13.2 BUYING CRITERIA
  • 5.14 CASE STUDY ANALYSIS
    • 5.14.1 CASE STUDY 1: IMPACT OF CCG-WIDE INSULIN PEN NEEDLE
    • 5.14.2 CASE STUDY 2: PEN NEEDLE DESIGN INFLUENCES EASE INSERTION, PAIN, AND SKIN TRAUMA IN SUBJECTS WITH TYPE 2 DIABETES
    • 5.14.3 CASE STUDY 3: DROPSAFE SAFETY PEN NEEDLE HELPS TO PREVENT ACCIDENTAL NEEDLESTICKS AFTER INJECTIONS
  • 5.15 TECHNOLOGY ANALYSIS
    • 5.15.1 KEY TECHNOLOGIES
      • 5.15.1.1 Fluid flow enhancement technology
      • 5.15.1.2 Ultra-thin needle technology
    • 5.15.2 COMPLEMENTARY TECHNOLOGIES
      • 5.15.2.1 Microfabricated needles
      • 5.15.2.2 AI in pen injectors
    • 5.15.3 ADJACENT TECHNOLOGIES
      • 5.15.3.1 Autoinjectors
  • 5.16 KEY CONFERENCES & EVENTS, 2025-2026
  • 5.17 ADJACENT MARKET ANALYSIS
    • 5.17.1 AUTOINJECTORS MARKET
    • 5.17.2 INSULIN DELIVERY DEVICES MARKET
    • 5.17.3 INJECTION PENS MARKET
    • 5.17.4 NEEDLES MARKET
  • 5.18 IMPACT OF AI/GEN AI ON PEN NEEDLES MARKET
  • 5.19 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESS
  • 5.20 UNMET NEEDS ANALYSIS
  • 5.21 INVESTMENT & FUNDING SCENARIO

6 PEN NEEDLES MARKET, BY TYPE

  • 6.1 INTRODUCTION
  • 6.2 STANDARD PEN NEEDLES
    • 6.2.1 GREATER PREFERENCE AND AFFORDABILITY OF STANDARD PEN NEEDLES TO SUPPORT GROWTH
  • 6.3 SAFETY PEN NEEDLES
    • 6.3.1 GROWING CONCERNS OVER NEEDLESTICK INJURIES TO DRIVE ADOPTION OF SAFETY PEN NEEDLES

7 PEN NEEDLES MARKET, BY LENGTH

  • 7.1 INTRODUCTION
  • 7.2 8MM
    • 7.2.1 WIDE ADOPTION IN NORTH AMERICA TO BOOST MARKET GROWTH
  • 7.3 5MM
    • 7.3.1 SHORTER LENGTH AND LOW PAIN TO FUEL UPTAKE
  • 7.4 6MM
    • 7.4.1 FAVORABLE REIMBURSEMENTS TO BOOST DEMAND
  • 7.5 4MM
    • 7.5.1 WIDE ADOPTION IN PEDIATRIC INSULIN DELIVERY TO DRIVE DEMAND
  • 7.6 12MM
    • 7.6.1 HIGH UTILIZATION OF SHORTER NEEDLES TO LIMIT ADOPTION
  • 7.7 10MM
    • 7.7.1 PAINFUL PROCEDURES TO RESTRAIN ADOPTION

8 PEN NEEDLES MARKET, BY APPLICATION

  • 8.1 INTRODUCTION
  • 8.2 INSULIN THERAPY
    • 8.2.1 RISING INCIDENCE OF DIABETES TO PROPEL MARKET
  • 8.3 GLUCAGON-LIKE PEPTIDE-1 THERAPY
    • 8.3.1 GROWING FOCUS OF PHARMA COMPANIES ON GLP-1 DRUG DEVELOPMENT TO DRIVE MARKET
  • 8.4 GROWTH HORMONE THERAPY
    • 8.4.1 AVAILABILITY OF LONG-ACTING TREATMENTS TO AFFECT DEMAND FOR NEEDLES
  • 8.5 OSTEOPOROSIS
    • 8.5.1 RISING VITAMIN D DEFICIENCY CASES TO PROPEL MARKET
  • 8.6 OTHER APPLICATIONS

9 PEN NEEDLES MARKET, BY MODE OF PURCHASE

  • 9.1 INTRODUCTION
  • 9.2 PRESCRIPTION-BASED PURCHASE
    • 9.2.1 RETAIL PURCHASES TO SUPPORT MARKET GROWTH
  • 9.3 OTC PURCHASES
    • 9.3.1 DISCOUNTS OFFERED BY LOCAL PHARMACIES, SUPPLIERS, AND DISTRIBUTORS TO DRIVE MARKET
  • 9.4 ONLINE PURCHASE
    • 9.4.1 CONVENIENCE AND TIME-EFFICIENT BENEFITS TO PROPEL MARKET
  • 9.5 OTHER MODES OF PURCHASE

10 PEN NEEDLES MARKET, BY CARE SETTING

  • 10.1 INTRODUCTION
  • 10.2 HOME CARE SETTINGS
    • 10.2.1 GROWING PREFERENCE FOR SELF-ADMINISTRATION OF INSULIN TO PROPEL MARKET
  • 10.3 HOSPITALS & CLINICS
    • 10.3.1 INCREASING ADOPTION OF SAFETY PEN NEEDLES TO DRIVE MARKET
  • 10.4 OTHER CARE SETTINGS

11 PEN NEEDLES MARKET, BY REGION

  • 11.1 INTRODUCTION
  • 11.2 NORTH AMERICA
    • 11.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
    • 11.2.2 US
      • 11.2.2.1 Increasing burden of diabetes to contribute to growth
    • 11.2.3 CANADA
      • 11.2.3.1 Growing initiatives for diabetic coverage to drive market
  • 11.3 EUROPE
    • 11.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
    • 11.3.2 GERMANY
      • 11.3.2.1 Advanced healthcare system to intensify growth
    • 11.3.3 UK
      • 11.3.3.1 High incidence of cardiovascular disease to favor growth
    • 11.3.4 FRANCE
      • 11.3.4.1 Growing delivery of insulin devices to propel market
    • 11.3.5 ITALY
      • 11.3.5.1 Low product pricing to support growth
    • 11.3.6 SPAIN
      • 11.3.6.1 Supportive regulations mandating the use of safety pen needles to propel market
    • 11.3.7 REST OF EUROPE
  • 11.4 ASIA PACIFIC
    • 11.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
    • 11.4.2 JAPAN
      • 11.4.2.1 Growing inclination toward public health insurance to boost market
    • 11.4.3 CHINA
      • 11.4.3.1 Rising focus on modernizing healthcare to expedite growth
    • 11.4.4 AUSTRALIA & NEW ZEALAND
      • 11.4.4.1 Increasing rate of chronic diseases to amplify growth
    • 11.4.5 INDIA
      • 11.4.5.1 Growing per capita income to fuel market
    • 11.4.6 SOUTH KOREA
      • 11.4.6.1 Increasing geriatric population to facilitate growth
    • 11.4.7 SOUTHEAST ASIA
      • 11.4.7.1 Booming medical tourism industry to drive market
    • 11.4.8 REST OF ASIA PACIFIC
  • 11.5 LATIN AMERICA
    • 11.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
    • 11.5.2 BRAZIL
      • 11.5.2.1 Growing incidence of non-communicable diseases to drive market
    • 11.5.3 MEXICO
      • 11.5.3.1 Universal health coverage to stimulate growth
    • 11.5.4 ARGENTINA
      • 11.5.4.1 Increasing obesity rates to bolster growth
    • 11.5.5 REST OF LATIN AMERICA
  • 11.6 MIDDLE EAST & AFRICA
    • 11.6.1 INCREASING PREVALENCE OF CHRONIC DISEASES TO AUGMENT GROWTH
    • 11.6.2 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
  • 11.7 GCC COUNTRIES
    • 11.7.1 HIGHER DISPOSABLE INCOME TO ENCOURAGE GROWTH
    • 11.7.2 MACROECONOMIC OUTLOOK FOR GCC COUNTRIES

12 COMPETITIVE LANDSCAPE

  • 12.1 INTRODUCTION
  • 12.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
    • 12.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN PEN NEEDLES MARKET
  • 12.3 REVENUE ANALYSIS, 2019-2023
  • 12.4 MARKET SHARE ANALYSIS, 2023
  • 12.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
    • 12.5.1 STARS
    • 12.5.2 EMERGING LEADERS
    • 12.5.3 PERVASIVE PLAYERS
    • 12.5.4 PARTICIPANTS
    • 12.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
      • 12.5.5.1 Company footprint
      • 12.5.5.2 Region footprint
      • 12.5.5.3 Type footprint
      • 12.5.5.4 Length footprint
      • 12.5.5.5 Application footprint
  • 12.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
    • 12.6.1 PROGRESSIVE COMPANIES
    • 12.6.2 RESPONSIVE COMPANIES
    • 12.6.3 DYNAMIC COMPANIES
    • 12.6.4 STARTING BLOCKS
    • 12.6.5 COMPETITIVE BENCHMARKING
      • 12.6.5.1 Detailed list of key startups/SMEs
      • 12.6.5.2 Competitive benchmarking of key startups/SMEs
  • 12.7 COMPANY VALUATION & FINANCIAL METRICS
  • 12.8 COMPETITIVE SCENARIO
    • 12.8.1 PRODUCT LAUNCHES & APPROVALS
    • 12.8.2 DEALS
    • 12.8.3 EXPANSIONS
  • 12.9 BRAND/PRODUCT COMPARISON
  • 12.10 R&D EXPENDITURE OF KEY PLAYERS

13 COMPANY PROFILES

  • 13.1 KEY PLAYERS
    • 13.1.1 EMBECTA CORP.
      • 13.1.1.1 Business overview
      • 13.1.1.2 Products offered
      • 13.1.1.3 Recent developments
        • 13.1.1.3.1 Deals
        • 13.1.1.3.2 Expansions
        • 13.1.1.3.3 Other developments
      • 13.1.1.4 MnM view
        • 13.1.1.4.1 Right to win
        • 13.1.1.4.2 Strategic choices
        • 13.1.1.4.3 Weaknesses & competitive threats
    • 13.1.2 NOVO NORDISK A/S
      • 13.1.2.1 Business overview
      • 13.1.2.2 Products offered
      • 13.1.2.3 Recent developments
        • 13.1.2.3.1 Expansions
      • 13.1.2.4 MnM view
        • 13.1.2.4.1 Right to win
        • 13.1.2.4.2 Strategic choices
        • 13.1.2.4.3 Weaknesses & competitive threats
    • 13.1.3 B. BRAUN SE
      • 13.1.3.1 Business overview
      • 13.1.3.2 Products offered
      • 13.1.3.3 MnM view
        • 13.1.3.3.1 Right to win
        • 13.1.3.3.2 Strategic choices
        • 13.1.3.3.3 Weaknesses & competitive threats
    • 13.1.4 YPSOMED
      • 13.1.4.1 Business overview
      • 13.1.4.2 Products offered
      • 13.1.4.3 Recent developments
        • 13.1.4.3.1 Deals
      • 13.1.4.4 MnM view
        • 13.1.4.4.1 Right to win
        • 13.1.4.4.2 Strategic choices
        • 13.1.4.4.3 Weaknesses & competitive threats
    • 13.1.5 TERUMO CORPORATION
      • 13.1.5.1 Business overview
      • 13.1.5.2 Products offered
      • 13.1.5.3 MnM view
        • 13.1.5.3.1 Right to win
        • 13.1.5.3.2 Strategic choices
        • 13.1.5.3.3 Weaknesses & competitive threats
    • 13.1.6 NIPRO
      • 13.1.6.1 Business overview
      • 13.1.6.2 Products offered
      • 13.1.6.3 Recent developments
        • 13.1.6.3.1 Expansions
    • 13.1.7 OWEN MUMFORD
      • 13.1.7.1 Business overview
      • 13.1.7.2 Products offered
      • 13.1.7.3 Recent developments
        • 13.1.7.3.1 Deals
    • 13.1.8 ARKRAY, INC.
      • 13.1.8.1 Business overview
      • 13.1.8.2 Products offered
      • 13.1.8.3 Recent developments
        • 13.1.8.3.1 Expansions
    • 13.1.9 ULTIMED, INC.
      • 13.1.9.1 Business overview
      • 13.1.9.2 Products offered
      • 13.1.9.3 Recent developments
        • 13.1.9.3.1 Product launches
    • 13.1.10 HINDUSTAN SYRINGES & MEDICAL DEVICES LTD.
      • 13.1.10.1 Business overview
      • 13.1.10.2 Products offered
    • 13.1.11 MONTMED
      • 13.1.11.1 Business overview
      • 13.1.11.2 Products offered
      • 13.1.11.3 Recent developments
        • 13.1.11.3.1 Product approvals
        • 13.1.11.3.2 Deals
    • 13.1.12 HTL-STREFA
      • 13.1.12.1 Business overview
      • 13.1.12.2 Products offered
    • 13.1.13 ALLISON MEDICAL, INC.
      • 13.1.13.1 Business overview
      • 13.1.13.2 Products offered
    • 13.1.14 GLUCORX LIMITED
      • 13.1.14.1 Business overview
      • 13.1.14.2 Products offered
    • 13.1.15 BERPU MEDICAL TECHNOLOGY CO., LTD.
      • 13.1.15.1 Business overview
      • 13.1.15.2 Products offered
  • 13.2 OTHER PLAYERS
    • 13.2.1 VAN HEEK MEDICAL
    • 13.2.2 SIMPLE DIAGNOSTICS
    • 13.2.3 IYON HEALTH MEDICAL
    • 13.2.4 LINKS MEDICAL PRODUCTS INC.
    • 13.2.5 MHC MEDICAL PRODUCTS, LLC
    • 13.2.6 ADVACARE PHARMA
    • 13.2.7 ARTSANA S.P.A.
    • 13.2.8 PROMISEMED MEDICAL DEVICES, INC.
    • 13.2.9 TRIVIDIA HEALTH, INC.
    • 13.2.10 VOGT MEDICAL VERTRIEB GMBH

14 APPENDIX

  • 14.1 DISCUSSION GUIDE
  • 14.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 14.3 CUSTOMIZATION OPTIONS
  • 14.4 RELATED REPORTS
  • 14.5 AUTHOR DETAILS

List of Tables

  • TABLE 1 STANDARD CURRENCY CONVERSION RATES
  • TABLE 2 PEN NEEDLES MARKET: STUDY ASSUMPTIONS
  • TABLE 3 PEN NEEDLES MARKET: RISK ASSESSMENT ANALYSIS
  • TABLE 4 REIMBURSEMENT OF PEN NEEDLES, BY COUNTRY
  • TABLE 5 INDICATIVE SELLING PRICE OF PEN NEEDLES, BY KEY PLAYER, 2024
  • TABLE 6 PEN NEEDLES MARKET: ROLE IN ECOSYSTEM
  • TABLE 7 PEN NEEDLES MARKET: PORTER'S FIVE FORCES ANALYSIS
  • TABLE 8 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 9 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 10 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 11 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 12 US FDA: MEDICAL DEVICE CLASSIFICATION
  • TABLE 13 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
  • TABLE 14 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
  • TABLE 15 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA
  • TABLE 16 CHINA: REGULATORY BODIES APPOINTED FOR MEDICAL DEVICE APPROVAL
  • TABLE 17 CHINA: CLASSIFICATION OF MEDICAL DEVICES
  • TABLE 18 TRADE ANALYSIS OF NEEDLES, CATHETERS, AND CANNULAE USED IN MEDICAL, SURGICAL, DENTAL, OR VETERINARY SCIENCES, 2023 (USD MILLION)
  • TABLE 19 EXPORT DATA FOR NEEDLES, CATHETERS, AND CANNULAE USED IN MEDICAL, SURGICAL, DENTAL, OR VETERINARY SCIENCES (HS CODE 901839), BY COUNTRY, 2019-2023 (USD THOUSAND)
  • TABLE 20 IMPORT DATA FOR NEEDLES, CATHETERS, AND CANNULAE USED IN MEDICAL, SURGICAL, DENTAL, OR VETERINARY SCIENCES (HS CODE 901839), BY COUNTRY, 2019-2023 (USD THOUSAND)
  • TABLE 21 PEN INJECTORS MARKET: MAJOR PATENTS
  • TABLE 22 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR PEN NEEDLES
  • TABLE 23 KEY BUYING CRITERIA FOR PEN NEEDLES
  • TABLE 24 IMPACT OF CCG-WIDE INSULIN PEN NEEDLE
  • TABLE 25 PEN NEEDLE DESIGN INFLUENCES EASE OF INSERTION, PAIN, AND SKIN TRAUMA IN SUBJECTS WITH TYPE 2 DIABETES
  • TABLE 26 DROPSAFE SAFETY PEN NEEDLE HELPS TO PREVENT ACCIDENTAL NEEDLESTICKS AFTER INJECTIONS
  • TABLE 27 PEN NEEDLES MARKET: DETAILED LIST OF CONFERENCES & EVENTS (2025-2026)
  • TABLE 28 PEN NEEDLES MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 29 STANDARD PEN NEEDLES OFFERED BY KEY PLAYERS
  • TABLE 30 STANDARD PEN NEEDLES MARKET, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 31 STANDARD PEN NEEDLES MARKET, BY REGION, 2022-2030 (MILLION UNITS)
  • TABLE 32 SAFETY PEN NEEDLES OFFERED BY KEY PLAYERS
  • TABLE 33 SAFETY PEN NEEDLES MARKET, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 34 SAFETY PEN NEEDLES MARKET, BY REGION, 2022-2030 (MILLION UNITS)
  • TABLE 35 PEN NEEDLES MARKET, BY LENGTH, 2022-2030 (USD MILLION)
  • TABLE 36 8MM PEN NEEDLES OFFERED BY KEY PLAYERS
  • TABLE 37 8MM PEN NEEDLES MARKET, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 38 5MM PEN NEEDLES OFFERED BY KEY PLAYERS
  • TABLE 39 5MM PEN NEEDLES MARKET, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 40 6MM PEN NEEDLES OFFERED BY KEY PLAYERS
  • TABLE 41 6MM PEN NEEDLES MARKET, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 42 4MM PEN NEEDLES OFFERED BY KEY PLAYERS
  • TABLE 43 4MM PEN NEEDLES MARKET, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 44 12MM PEN NEEDLES OFFERED BY KEY PLAYERS
  • TABLE 45 12MM PEN NEEDLES MARKET, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 46 10MM PEN NEEDLES OFFERED BY KEY PLAYERS
  • TABLE 47 10MM PEN NEEDLES MARKET, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 48 PEN NEEDLES MARKET, BY APPLICATION, 2022-2030 (USD MILLION)
  • TABLE 49 PEN NEEDLES MARKET FOR INSULIN THERAPY, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 50 PEN NEEDLES MARKET FOR GLP-1 THERAPY, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 51 PEN NEEDLES MARKET FOR GROWTH HORMONE THERAPY, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 52 PEN NEEDLES MARKET FOR OSTEOPOROSIS, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 53 PEN NEEDLES MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 54 PEN NEEDLES MARKET, BY MODE OF PURCHASE, 2022-2030 (USD MILLION)
  • TABLE 55 PEN NEEDLES MARKET FOR PRESCRIPTION-BASED PURCHASES, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 56 PEN NEEDLES MARKET FOR OTC PURCHASES, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 57 PEN NEEDLES MARKET FOR ONLINE PURCHASES, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 58 PEN NEEDLES MARKET FOR OTHER MODES OF PURCHASE, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 59 PEN NEEDLES MARKET, BY CARE SETTING, 2022-2030 (USD MILLION)
  • TABLE 60 PEN NEEDLES MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 61 PEN NEEDLES MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 62 PEN NEEDLES MARKET FOR OTHER CARE SETTINGS, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 63 PEN NEEDLES MARKET, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 64 NORTH AMERICA: PEN NEEDLES MARKET, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 65 NORTH AMERICA: PEN NEEDLES MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 66 NORTH AMERICA: PEN NEEDLES MARKET, BY LENGTH, 2022-2030 (USD MILLION)
  • TABLE 67 NORTH AMERICA: PEN NEEDLES MARKET, BY APPLICATION, 2022-2030 (USD MILLION)
  • TABLE 68 NORTH AMERICA: PEN NEEDLES MARKET, BY MODE OF PURCHASE, 2022-2030 (USD MILLION)
  • TABLE 69 NORTH AMERICA: PEN NEEDLES MARKET, BY CARE SETTING, 2022-2030 (USD MILLION)
  • TABLE 70 MACROECONOMIC INDICATORS FOR US
  • TABLE 71 US: PEN NEEDLES MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 72 US: PEN NEEDLES MARKET, BY LENGTH, 2022-2030 (USD MILLION)
  • TABLE 73 US: PEN NEEDLES MARKET, BY APPLICATION, 2022-2030 (USD MILLION)
  • TABLE 74 US: PEN NEEDLES MARKET, BY MODE OF PURCHASE, 2022-2030 (USD MILLION)
  • TABLE 75 US: PEN NEEDLES MARKET, BY CARE SETTING, 2022-2030 (USD MILLION)
  • TABLE 76 MACROECONOMIC INDICATORS FOR CANADA
  • TABLE 77 CANADA: PEN NEEDLES MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 78 CANADA: PEN NEEDLES MARKET, BY LENGTH, 2022-2030 (USD MILLION)
  • TABLE 79 CANADA: PEN NEEDLES MARKET, BY APPLICATION, 2022-2030 (USD MILLION)
  • TABLE 80 CANADA: PEN NEEDLES MARKET, BY MODE OF PURCHASE, 2022-2030 (USD MILLION)
  • TABLE 81 CANADA: PEN NEEDLES MARKET, BY CARE SETTING, 2022-2030 (USD MILLION)
  • TABLE 82 EUROPE: PEN NEEDLES MARKET, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 83 EUROPE: PEN NEEDLES MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 84 EUROPE: PEN NEEDLES MARKET, BY LENGTH, 2022-2030 (USD MILLION)
  • TABLE 85 EUROPE: PEN NEEDLES MARKET, BY APPLICATION, 2022-2030 (USD MILLION)
  • TABLE 86 EUROPE: PEN NEEDLES MARKET, BY MODE OF PURCHASE, 2022-2030 (USD MILLION)
  • TABLE 87 EUROPE: PEN NEEDLES MARKET, BY CARE SETTING, 2022-2030 (USD MILLION)
  • TABLE 88 MACROECONOMIC INDICATORS FOR GERMANY
  • TABLE 89 GERMANY: PEN NEEDLES MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 90 GERMANY: PEN NEEDLES MARKET, BY LENGTH, 2022-2030 (USD MILLION)
  • TABLE 91 GERMANY: PEN NEEDLES MARKET, BY APPLICATION, 2022-2030 (USD MILLION)
  • TABLE 92 GERMANY: PEN NEEDLES MARKET, BY MODE OF PURCHASE, 2022-2030 (USD MILLION)
  • TABLE 93 GERMANY: PEN NEEDLES MARKET, BY CARE SETTING, 2022-2030 (USD MILLION)
  • TABLE 94 MACROECONOMIC INDICATORS FOR UK
  • TABLE 95 UK: PEN NEEDLES MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 96 UK: PEN NEEDLES MARKET, BY LENGTH, 2022-2030 (USD MILLION)
  • TABLE 97 UK: PEN NEEDLES MARKET, BY APPLICATION, 2022-2030 (USD MILLION)
  • TABLE 98 UK: PEN NEEDLES MARKET, BY MODE OF PURCHASE, 2022-2030 (USD MILLION)
  • TABLE 99 UK: PEN NEEDLES MARKET, BY CARE SETTING, 2022-2030 (USD MILLION)
  • TABLE 100 MACROECONOMIC INDICATORS FOR FRANCE
  • TABLE 101 FRANCE: PEN NEEDLES MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 102 FRANCE: PEN NEEDLES MARKET, BY LENGTH, 2022-2030 (USD MILLION)
  • TABLE 103 FRANCE: PEN NEEDLES MARKET, BY APPLICATION, 2022-2030 (USD MILLION)
  • TABLE 104 FRANCE: PEN NEEDLES MARKET, BY MODE OF PURCHASE, 2022-2030 (USD MILLION)
  • TABLE 105 FRANCE: PEN NEEDLES MARKET, BY CARE SETTING, 2022-2030 (USD MILLION)
  • TABLE 106 MACROECONOMIC INDICATORS FOR ITALY
  • TABLE 107 ITALY: PEN NEEDLES MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 108 ITALY: PEN NEEDLES MARKET, BY LENGTH, 2022-2030 (USD MILLION)
  • TABLE 109 ITALY: PEN NEEDLES MARKET, BY APPLICATION, 2022-2030 (USD MILLION)
  • TABLE 110 ITALY: PEN NEEDLES MARKET, BY MODE OF PURCHASE, 2022-2030 (USD MILLION)
  • TABLE 111 ITALY: PEN NEEDLES MARKET, BY CARE SETTING, 2022-2030 (USD MILLION)
  • TABLE 112 MACROECONOMIC INDICATORS FOR SPAIN
  • TABLE 113 SPAIN: PEN NEEDLES MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 114 SPAIN: PEN NEEDLES MARKET, BY LENGTH, 2022-2030 (USD MILLION)
  • TABLE 115 SPAIN: PEN NEEDLES MARKET, BY APPLICATION, 2022-2030 (USD MILLION)
  • TABLE 116 SPAIN: PEN NEEDLES MARKET, BY MODE OF PURCHASE, 2022-2030 (USD MILLION)
  • TABLE 117 SPAIN: PEN NEEDLES MARKET, BY CARE SETTING, 2022-2030 (USD MILLION)
  • TABLE 118 REST OF EUROPE: PEN NEEDLES MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 119 REST OF EUROPE: PEN NEEDLES MARKET, BY LENGTH, 2022-2030 (USD MILLION)
  • TABLE 120 REST OF EUROPE: PEN NEEDLES MARKET, BY APPLICATION, 2022-2030 (USD MILLION)
  • TABLE 121 REST OF EUROPE: PEN NEEDLES MARKET, BY MODE OF PURCHASE, 2022-2030 (USD MILLION)
  • TABLE 122 REST OF EUROPE: PEN NEEDLES MARKET, BY CARE SETTING, 2022-2030 (USD MILLION)
  • TABLE 123 ASIA PACIFIC: PEN NEEDLES MARKET, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 124 ASIA PACIFIC: PEN NEEDLES MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 125 ASIA PACIFIC: PEN NEEDLES MARKET, BY LENGTH, 2022-2030 (USD MILLION)
  • TABLE 126 ASIA PACIFIC: PEN NEEDLES MARKET, BY APPLICATION, 2022-2030 (USD MILLION)
  • TABLE 127 ASIA PACIFIC: PEN NEEDLES MARKET, BY MODE OF PURCHASE, 2022-2030 (USD MILLION)
  • TABLE 128 ASIA PACIFIC: PEN NEEDLES MARKET, BY CARE SETTING, 2022-2030 (USD MILLION)
  • TABLE 129 MACROECONOMIC INDICATORS FOR JAPAN
  • TABLE 130 JAPAN: PEN NEEDLES MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 131 JAPAN: PEN NEEDLES MARKET, BY LENGTH, 2022-2030 (USD MILLION)
  • TABLE 132 JAPAN: PEN NEEDLES MARKET, BY APPLICATION, 2022-2030 (USD MILLION)
  • TABLE 133 JAPAN: PEN NEEDLES MARKET, BY MODE OF PURCHASE, 2022-2030 (USD MILLION)
  • TABLE 134 JAPAN: PEN NEEDLES MARKET, BY CARE SETTING, 2022-2030 (USD MILLION)
  • TABLE 135 MACROECONOMIC INDICATORS FOR CHINA
  • TABLE 136 CHINA: PEN NEEDLES MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 137 CHINA: PEN NEEDLES MARKET, BY LENGTH, 2022-2030 (USD MILLION)
  • TABLE 138 CHINA: PEN NEEDLES MARKET, BY APPLICATION, 2022-2030 (USD MILLION)
  • TABLE 139 CHINA: PEN NEEDLES MARKET, BY MODE OF PURCHASE, 2022-2030 (USD MILLION)
  • TABLE 140 CHINA: PEN NEEDLES MARKET, BY CARE SETTING, 2022-2030 (USD MILLION)
  • TABLE 141 AUSTRALIA & NEW ZEALAND: PEN NEEDLES MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 142 AUSTRALIA & NEW ZEALAND: PEN NEEDLES MARKET, BY LENGTH, 2022-2030 (USD MILLION)
  • TABLE 143 AUSTRALIA & NEW ZEALAND: PEN NEEDLES MARKET, BY APPLICATION, 2022-2030 (USD MILLION)
  • TABLE 144 AUSTRALIA & NEW ZEALAND: PEN NEEDLES MARKET, BY MODE OF PURCHASE, 2022-2030 (USD MILLION)
  • TABLE 145 AUSTRALIA & NEW ZEALAND: PEN NEEDLES MARKET, BY CARE SETTING, 2022-2030 (USD MILLION)
  • TABLE 146 MACROECONOMIC INDICATORS FOR INDIA
  • TABLE 147 INDIA: PEN NEEDLES MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 148 INDIA: PEN NEEDLES MARKET, BY LENGTH, 2022-2030 (USD MILLION)
  • TABLE 149 INDIA: PEN NEEDLES MARKET, BY APPLICATION, 2022-2030 (USD MILLION)
  • TABLE 150 INDIA: PEN NEEDLES MARKET, BY MODE OF PURCHASE, 2022-2030 (USD MILLION)
  • TABLE 151 INDIA: PEN NEEDLES MARKET, BY CARE SETTING, 2022-2030 (USD MILLION)
  • TABLE 152 MACROECONOMIC INDICATORS FOR SOUTH KOREA
  • TABLE 153 SOUTH KOREA: PEN NEEDLES MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 154 SOUTH KOREA: PEN NEEDLES MARKET, BY LENGTH, 2022-2030 (USD MILLION)
  • TABLE 155 SOUTH KOREA: PEN NEEDLES MARKET, BY APPLICATION, 2022-2030 (USD MILLION)
  • TABLE 156 SOUTH KOREA: PEN NEEDLES MARKET, BY MODE OF PURCHASE, 2022-2030 (USD MILLION)
  • TABLE 157 SOUTH KOREA: PEN NEEDLES MARKET, BY CARE SETTING, 2022-2030 (USD MILLION)
  • TABLE 158 SOUTHEAST ASIA: PEN NEEDLES MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 159 SOUTHEAST ASIA: PEN NEEDLES MARKET, BY LENGTH, 2022-2030 (USD MILLION)
  • TABLE 160 SOUTHEAST ASIA: PEN NEEDLES MARKET, BY APPLICATION, 2022-2030 (USD MILLION)
  • TABLE 161 SOUTHEAST ASIA: PEN NEEDLES MARKET, BY MODE OF PURCHASE, 2022-2030 (USD MILLION)
  • TABLE 162 SOUTHEAST ASIA: PEN NEEDLES MARKET, BY CARE SETTING, 2022-2030 (USD MILLION)
  • TABLE 163 REST OF ASIA PACIFIC: PEN NEEDLES MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 164 REST OF ASIA PACIFIC: PEN NEEDLES MARKET, BY LENGTH, 2022-2030 (USD MILLION)
  • TABLE 165 REST OF ASIA PACIFIC: PEN NEEDLES MARKET, BY APPLICATION, 2022-2030 (USD MILLION)
  • TABLE 166 REST OF ASIA PACIFIC: PEN NEEDLES MARKET, BY MODE OF PURCHASE, 2022-2030 (USD MILLION)
  • TABLE 167 REST OF ASIA PACIFIC: PEN NEEDLES MARKET, BY CARE SETTING, 2022-2030 (USD MILLION)
  • TABLE 168 LATIN AMERICA: PEN NEEDLES MARKET, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 169 LATIN AMERICA: PEN NEEDLES MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 170 LATIN AMERICA: PEN NEEDLES MARKET, BY LENGTH, 2022-2030 (USD MILLION)
  • TABLE 171 LATIN AMERICA: PEN NEEDLES MARKET, BY APPLICATION, 2022-2030 (USD MILLION)
  • TABLE 172 LATIN AMERICA: PEN NEEDLES MARKET, BY MODE OF PURCHASE, 2022-2030 (USD MILLION)
  • TABLE 173 LATIN AMERICA: PEN NEEDLES MARKET, BY CARE SETTING, 2022-2030 (USD MILLION)
  • TABLE 174 MACROECONOMIC INDICATORS FOR BRAZIL
  • TABLE 175 BRAZIL: PEN NEEDLES MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 176 BRAZIL: PEN NEEDLES MARKET, BY LENGTH, 2022-2030 (USD MILLION)
  • TABLE 177 BRAZIL: PEN NEEDLES MARKET, BY APPLICATION, 2022-2030 (USD MILLION)
  • TABLE 178 BRAZIL: PEN NEEDLES MARKET, BY MODE OF PURCHASE, 2022-2030 (USD MILLION)
  • TABLE 179 BRAZIL: PEN NEEDLES MARKET, BY CARE SETTING, 2022-2030 (USD MILLION)
  • TABLE 180 MACROECONOMIC INDICATORS FOR MEXICO
  • TABLE 181 MEXICO: PEN NEEDLES MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 182 MEXICO: PEN NEEDLES MARKET, BY LENGTH, 2022-2030 (USD MILLION)
  • TABLE 183 MEXICO: PEN NEEDLES MARKET, BY APPLICATION, 2022-2030 (USD MILLION)
  • TABLE 184 MEXICO: PEN NEEDLES MARKET, BY MODE OF PURCHASE, 2022-2030 (USD MILLION)
  • TABLE 185 MEXICO: PEN NEEDLES MARKET, BY CARE SETTING, 2022-2030 (USD MILLION)
  • TABLE 186 MACROECONOMIC INDICATORS FOR ARGENTINA
  • TABLE 187 ARGENTINA: PEN NEEDLES MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 188 ARGENTINA: PEN NEEDLES MARKET, BY LENGTH, 2022-2030 (USD MILLION)
  • TABLE 189 ARGENTINA: PEN NEEDLES MARKET, BY APPLICATION, 2022-2030 (USD MILLION)
  • TABLE 190 ARGENTINA: PEN NEEDLES MARKET, BY MODE OF PURCHASE, 2022-2030 (USD MILLION)
  • TABLE 191 ARGENTINA: PEN NEEDLES MARKET, BY CARE SETTING, 2022-2030 (USD MILLION)
  • TABLE 192 REST OF LATIN AMERICA: PEN NEEDLES MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 193 REST OF LATIN AMERICA: PEN NEEDLES MARKET, BY LENGTH, 2022-2030 (USD MILLION)
  • TABLE 194 REST OF LATIN AMERICA: PEN NEEDLES MARKET, BY APPLICATION, 2022-2030 (USD MILLION)
  • TABLE 195 REST OF LATIN AMERICA: PEN NEEDLES MARKET, BY MODE OF PURCHASE, 2022-2030 (USD MILLION)
  • TABLE 196 REST OF LATIN AMERICA: PEN NEEDLES MARKET, BY CARE SETTING, 2022-2030 (USD MILLION)
  • TABLE 197 MIDDLE EAST & AFRICA: PEN NEEDLES MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 198 MIDDLE EAST & AFRICA: PEN NEEDLES MARKET, BY LENGTH, 2022-2030 (USD MILLION)
  • TABLE 199 MIDDLE EAST & AFRICA: PEN NEEDLES MARKET, BY APPLICATION, 2022-2030 (USD MILLION)
  • TABLE 200 MIDDLE EAST & AFRICA: PEN NEEDLES MARKET, BY MODE OF PURCHASE, 2022-2030 (USD MILLION)
  • TABLE 201 MIDDLE EAST & AFRICA: PEN NEEDLES MARKET, BY CARE SETTING, 2022-2030 (USD MILLION)
  • TABLE 202 GCC COUNTRIES: PEN NEEDLES MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 203 GCC COUNTRIES: PEN NEEDLES MARKET, BY LENGTH, 2022-2030 (USD MILLION)
  • TABLE 204 GCC COUNTRIES: PEN NEEDLES MARKET, BY APPLICATION, 2022-2030 (USD MILLION)
  • TABLE 205 GCC COUNTRIES: PEN NEEDLES MARKET, BY MODE OF PURCHASE, 2022-2030 (USD MILLION)
  • TABLE 206 GCC COUNTRIES: PEN NEEDLES MARKET, BY CARE SETTING, 2022-2030 (USD MILLION)
  • TABLE 207 PEN NEEDLES MARKET: DEGREE OF COMPETITION
  • TABLE 208 PEN NEEDLES MARKET: REGION FOOTPRINT
  • TABLE 209 PEN NEEDLES MARKET: TYPE FOOTPRINT
  • TABLE 210 PEN NEEDLES MARKET: LENGTH FOOTPRINT
  • TABLE 211 PEN NEEDLES MARKET: APPLICATION FOOTPRINT
  • TABLE 212 PEN NEEDLES MARKET: DETAILED LIST OF KEY STARTUPS/SMES
  • TABLE 213 PEN NEEDLES MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
  • TABLE 214 PEN NEEDLES MARKET: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021- JANUARY 2025
  • TABLE 215 PEN NEEDLES MARKET: DEALS, JANUARY 2021- JANUARY 2025
  • TABLE 216 PEN NEEDLES MARKET: EXPANSIONS, JANUARY 2021- JANUARY 2025
  • TABLE 217 EMBECTA CORP.: COMPANY OVERVIEW
  • TABLE 218 EMBECTA CORP.: PRODUCTS OFFERED
  • TABLE 219 EMBECTA CORP.: DEALS, JANUARY 2021-JANUARY 2025
  • TABLE 220 EMBECTA CORP.: EXPANSIONS, JANUARY 2021-JANUARY 2025
  • TABLE 221 EMBECTA CORP.: OTHER DEVELOPMENTS, JANUARY 2021-JANUARY 2025
  • TABLE 222 NOVO NORDISK A/S: COMPANY OVERVIEW
  • TABLE 223 NOVO NORDISK A/S: PRODUCTS OFFERED
  • TABLE 224 NOVO NORDISK A/S: EXPANSIONS, JANUARY 2021-JANUARY 2025
  • TABLE 225 B. BRAUN SE: COMPANY OVERVIEW
  • TABLE 226 B. BRAUN SE: PRODUCTS OFFERED
  • TABLE 227 YPSOMED: COMPANY OVERVIEW
  • TABLE 228 YPSOMED: PRODUCTS OFFERED
  • TABLE 229 YPSOMED: DEALS, JANUARY 2021-JANUARY 2025
  • TABLE 230 TERUMO CORPORATION: COMPANY OVERVIEW
  • TABLE 231 TERUMO CORPORATION: PRODUCTS OFFERED
  • TABLE 232 NIPRO: COMPANY OVERVIEW
  • TABLE 233 NIPRO: PRODUCTS OFFERED
  • TABLE 234 NIPRO: EXPANSIONS, JANUARY 2021-JANUARY 2025
  • TABLE 235 OWEN MUMFORD: COMPANY OVERVIEW
  • TABLE 236 OWEN MUMFORD: PRODUCTS OFFERED
  • TABLE 237 OWEN MUMFORD: DEALS, JANUARY 2021-JANUARY 2025
  • TABLE 238 ARKRAY, INC.: COMPANY OVERVIEW
  • TABLE 239 ARKRAY, INC.: PRODUCTS OFFERED
  • TABLE 240 ARKRAY, INC.: EXPANSIONS, JANUARY 2021-JANUARY 2025
  • TABLE 241 ULTIMED, INC.: COMPANY OVERVIEW
  • TABLE 242 ULTIMED, INC.: PRODUCTS OFFERED
  • TABLE 243 ULTIMED, INC.: PRODUCT LAUNCHES, JANUARY 2021-JANUARY 2025
  • TABLE 244 HINDUSTAN SYRINGES & MEDICAL DEVICES LTD.: COMPANY OVERVIEW
  • TABLE 245 HINDUSTAN SYRINGES & MEDICAL DEVICES LTD.: PRODUCTS OFFERED
  • TABLE 246 MONTMED: COMPANY OVERVIEW
  • TABLE 247 MONTMED: PRODUCTS OFFERED
  • TABLE 248 MONTMED: PRODUCT APPROVALS, JANUARY 2021-JANUARY 2025
  • TABLE 249 MONTMED: DEALS, JANUARY 2021-JANUARY 2025
  • TABLE 250 HTL-STREFA: COMPANY OVERVIEW
  • TABLE 251 HTL-STREFA: PRODUCTS OFFERED
  • TABLE 252 ALLISON MEDICAL, INC.: COMPANY OVERVIEW
  • TABLE 253 ALLISON MEDICAL, INC.: PRODUCTS OFFERED
  • TABLE 254 GLUCORX LIMITED: COMPANY OVERVIEW
  • TABLE 255 GLUCORX LIMITED: PRODUCTS OFFERED
  • TABLE 256 BERPU MEDICAL TECHNOLOGY CO., LTD.: COMPANY OVERVIEW
  • TABLE 257 BERPU MEDICAL TECHNOLOGY CO., LTD.: PRODUCTS OFFERED
  • TABLE 258 VAN HEEK MEDICAL: COMPANY OVERVIEW
  • TABLE 259 SIMPLE DIAGNOSTICS: COMPANY OVERVIEW
  • TABLE 260 IYON HEALTH MEDICAL: COMPANY OVERVIEW
  • TABLE 261 LINKS MEDICAL PRODUCTS INC.: COMPANY OVERVIEW
  • TABLE 262 MHC MEDICAL PRODUCTS, LLC: COMPANY OVERVIEW
  • TABLE 263 ADVACARE PHARMA: COMPANY OVERVIEW
  • TABLE 264 ARTSANA S.P.A.: COMPANY OVERVIEW
  • TABLE 265 PROMISEMED MEDICAL DEVICES, INC.: COMPANY OVERVIEW
  • TABLE 266 TRIVIDIA HEALTH, INC.: COMPANY OVERVIEW
  • TABLE 267 VOGT MEDICAL VERTRIEB GMBH: COMPANY OVERVIEW

List of Figures

  • FIGURE 1 MARKETS & REGIONS COVERED
  • FIGURE 2 RESEARCH DESIGN
  • FIGURE 3 PRIMARY SOURCES
  • FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY CARE SETTING AND REGION
  • FIGURE 6 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
  • FIGURE 7 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
  • FIGURE 8 REVENUE SHARE ANALYSIS ILLUSTRATION: EMBECTA CORP. (2023)
  • FIGURE 9 PEN NEEDLES MARKET: REVENUE ANALYSIS OF TOP FIVE COMPANIES (2023)
  • FIGURE 10 DEMAND-SIDE ANALYSIS
  • FIGURE 11 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2024-2030)
  • FIGURE 12 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
  • FIGURE 13 TOP-DOWN APPROACH
  • FIGURE 14 DATA TRIANGULATION METHODOLOGY
  • FIGURE 15 PEN NEEDLES MARKET, BY TYPE, 2024 VS. 2030 (USD MILLION)
  • FIGURE 16 PEN NEEDLES MARKET, BY LENGTH, 2024 VS. 2030 (USD MILLION)
  • FIGURE 17 PEN NEEDLES MARKET, BY APPLICATION, 2024 VS. 2030 (USD MILLION)
  • FIGURE 18 PEN NEEDLES MARKET, BY MODE OF PURCHASE, 2024 VS. 2030 (USD MILLION)
  • FIGURE 19 PEN NEEDLES MARKET, BY CARE SETTING, 2024 VS. 2030 (USD MILLION)
  • FIGURE 20 GEOGRAPHIC GROWTH OPPORTUNITIES
  • FIGURE 21 RISING INCIDENCE OF DIABETES TO PROPEL MARKET
  • FIGURE 22 8MM SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN ASIA PACIFIC IN 2024
  • FIGURE 23 EMERGING MARKETS TO GROW AT HIGHER CAGRS DURING FORECAST PERIOD
  • FIGURE 24 NORTH AMERICA DOMINATED MARKET IN 2024
  • FIGURE 25 PEN NEEDLES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 26 NUMBER OF PEOPLE WITH CHRONIC CONDITIONS IN US, 1995-2030 (MILLION INDIVIDUALS)
  • FIGURE 27 TYPE 1 DIABETIC POPULATION, BY COUNTRY (2022)
  • FIGURE 28 AVERAGE SELLING PRICE TREND OF STANDARD PEN NEEDLES, BY REGION, 2022-2024 (USD)
  • FIGURE 29 PEN NEEDLES MARKET: VALUE CHAIN ANALYSIS
  • FIGURE 30 PEN NEEDLES MARKET: ECOSYSTEM ANALYSIS
  • FIGURE 31 PEN NEEDLES MARKET: PORTER'S FIVE FORCES ANALYSIS
  • FIGURE 32 PEN NEEDLES MARKET: SUPPLY CHAIN ANALYSIS
  • FIGURE 33 CANADA: CLASS II MEDICAL DEVICE APPROVAL PROCESS
  • FIGURE 34 EUROPE: CE APPROVAL PROCESS FOR CLASS IIA MEDICAL DEVICES
  • FIGURE 35 PATENT PUBLICATION TRENDS (JANUARY 2014-DECEMBER 2024)
  • FIGURE 36 TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) FOR PEN NEEDLE PATENTS (JANUARY 2014-DECEMBER 2024)
  • FIGURE 37 TOP APPLICANT COUNTRIES FOR PEN NEEDLE PATENTS (JANUARY 2013-DECEMBER 2024)
  • FIGURE 38 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR PEN NEEDLES
  • FIGURE 39 KEY BUYING CRITERIA FOR PEN NEEDLES, BY TYPE
  • FIGURE 40 AUTOINJECTORS MARKET OVERVIEW
  • FIGURE 41 INSULIN DELIVERY DEVICES MARKET OVERVIEW
  • FIGURE 42 INJECTION PENS MARKET OVERVIEW
  • FIGURE 43 NEEDLES MARKET OVERVIEW
  • FIGURE 44 IMPACT OF AI/GEN AI ON PEN NEEDLES MARKET
  • FIGURE 45 PEN NEEDLES MARKET: TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
  • FIGURE 46 FUNDING AND NUMBER OF DEALS IN PEN NEEDLES MARKET, 2018-2022 (USD MILLION)
  • FIGURE 47 NUMBER OF INVESTOR DEALS, BY KEY PLAYER, 2018-2022
  • FIGURE 48 VALUE OF INVESTOR DEALS, BY KEY PLAYER, 2018-2022 (USD MILLION)
  • FIGURE 49 NORTH AMERICA: PEN NEEDLES MARKET SNAPSHOT
  • FIGURE 50 TOTAL FERTILITY RATE IN US POPULATION, 1990-2024
  • FIGURE 51 ASIA PACIFIC: PEN NEEDLES MARKET SNAPSHOT
  • FIGURE 52 PREVALENCE OF DIABETES IN SOUTHEAST ASIA, 2021 VS. 2030
  • FIGURE 53 HEALTHCARE EXPENDITURE IN SOUTHEAST ASIA, 2021 (% GDP)
  • FIGURE 54 ELDERLY POPULATION IN SOUTHEAST ASIA, 2022
  • FIGURE 55 HEALTH EXPENDITURE IN LATIN AMERICA FOR 2021 (% GDP)
  • FIGURE 56 OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN PEN NEEDLES MARKET
  • FIGURE 57 REVENUE ANALYSIS FOR KEY PLAYERS IN PEN NEEDLES MARKET (2019-2023)
  • FIGURE 58 MARKET SHARE ANALYSIS OF KEY PLAYERS IN PEN NEEDLES MARKET (2023)
  • FIGURE 59 PEN NEEDLES MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023
  • FIGURE 60 PEN NEEDLES MARKET: COMPANY FOOTPRINT
  • FIGURE 61 PEN NEEDLES MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023
  • FIGURE 62 EV/EBITDA OF KEY VENDORS
  • FIGURE 63 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
  • FIGURE 64 PEN NEEDLES MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS
  • FIGURE 65 PEN NEEDLES MARKET: R&D EXPENDITURE OF KEY PLAYERS (2022 VS. 2023)
  • FIGURE 66 EMBECTA CORP.: COMPANY SNAPSHOT
  • FIGURE 67 NOVO NORDISK A/S: COMPANY SNAPSHOT
  • FIGURE 68 B. BRAUN SE: COMPANY SNAPSHOT
  • FIGURE 69 YPSOMED: COMPANY SNAPSHOT
  • FIGURE 70 TERUMO CORPORATION: COMPANY SNAPSHOT
  • FIGURE 71 NIPRO: COMPANY SNAPSHOT